Omnicell
OMCL
329 hedge funds and large institutions have $2.26B invested in Omnicell in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 152 increasing their positions, 92 reducing their positions, and 81 closing their positions.
150% more call options, than puts
Call options by funds: $3.68M | Put options by funds: $1.47M
65% more repeat investments, than reductions
Existing positions increased: 152 | Existing positions reduced: 92
2.72% less ownership
Funds ownership: 104.78% → 102.06% (-2.7%)
12% less funds holding
Funds holding: 374 → 329 (-45)
44% less capital invested
Capital invested by funds: $4.04B → $2.26B (-$1.78B)
49% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 81
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.9M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$42.9M |
| 3 |
D.E. Shaw & Co
New York
|
+$29M |
| 4 |
BlackRock
New York
|
+$24.8M |
| 5 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$21.4M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$62.9M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$60.2M |
| 3 |
Lazard Asset Management
New York
|
-$56.7M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$29.2M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$25M |
OMCL Hedge Fund Activity: Q4 2022 in Review
329 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q4 2022, worth a combined $2.26B — down 44% from $4.04B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of OMCL and 41 opened new positions — a net loss of 40 holders — while 92 trimmed existing stakes and 152 added.
The largest buyer was Wellington Management Group, adding an estimated $57.9M. The largest seller was Invesco, cutting an estimated $62.9M.
- 329 institutional investors held Omnicell (OMCL) as of Q4 2022, down from 374 in Q3 2022.
- Funds reported $2.26B of Omnicell stock for Q4 2022, down 44% quarter-over-quarter.
- 41 funds opened new Omnicell positions in Q4 2022 and 81 closed out, a net change of -40 holders.
- The largest Omnicell buyer in Q4 2022 was Wellington Management Group, an estimated $57.9M added.
- The largest Omnicell seller in Q4 2022 was Invesco, an estimated $62.9M sold.
Based on aggregated 13F filings for Q4 2022.